Rhythm Biosciences Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 27, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	58	15	15	90	246	179
Market Cap Growth	182.03%	-0.47%	-82.90%	-63.40%	37.60%	2147.99%
Enterprise Value	57	11	14	81	241	173
Last Close Price	0.17	0.05	0.06	0.40	1.13	0.86
PS Ratio	35.43	4.81	9.12	29.11	101.42	161.41
PB Ratio	27.24	23.25	17.77	15.34	33.40	104.83
P/TBV Ratio	44.49	-	30.04	16.43	35.44	143.74
EV/Sales Ratio	34.54	3.46	8.40	26.28	99.12	155.95
Debt / Equity Ratio	0.12	1.68	0.19	0.01	0.02	-
Net Debt / Equity Ratio	-0.68	-0.57	-0.68	-0.69	-1.01	-1.33
Net Debt / EBITDA Ratio	0.23	0.11	0.09	0.49	0.85	0.35
Net Debt / FCF Ratio	0.24	0.13	0.10	0.58	1.14	0.42
Asset Turnover	0.37	1.47	0.37	0.38	0.42	0.39
Quick Ratio	1.90	0.72	1.41	2.40	8.24	1.81
Current Ratio	2.31	0.84	1.58	4.03	8.34	1.86
Return on Equity (ROE)	-190.14%	-501.54%	-203.42%	-124.07%	-193.71%	-372.53%
Return on Assets (ROA)	-91.40%	-107.16%	-93.69%	-65.39%	-95.79%	-144.88%
Return on Capital Employed (ROCE)	-306.10%	-554.40%	-721.70%	-142.30%	-117.50%	-383.70%
Earnings Yield	-11.43%	-24.96%	-44.49%	-9.12%	-3.57%	-3.70%
FCF Yield	-10.51%	-19.19%	-40.35%	-7.83%	-2.65%	-3.06%
Buyback Yield / Dilution	-22.09%	-17.94%	-5.26%	-3.31%	-13.35%	-83.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.